雜志介紹

Journal Of Drugs In Dermatology雜志介紹

《Journal Of Drugs In Dermatology》是一本以English為主的未開放獲取國際優秀期刊，中文名稱皮膚科藥物雜志，本刊主要出版、報道醫學-DERMATOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為1.5，最新CiteScore 指數為2.2。

本刊近期中國學者發表的論文主要有：

• Split-face study of topical 23.8% L-ascorbic acid serum in treating photo-aged skin.

  Author: Xu TH, Chen JZ, Li YH, Wu Y, Luo YJ, Gao XH, Chen HD.

• Combined antibiotic/corticosteroid cream in the empirical treatment of moderate to severe eczema: friend or foe?

  Author: Hon KL, Wang SS, Lee KK, Lee VW, Leung TF, Ip M.

• The effect of combined calcipotriol and betamethasone dipropionate ointment in the treatment of vitiligo: an open, uncontrolled trial.

  Author: Xing C, Xu A.

• Split-face comparison of ultrapulse-mode and superpulse-mode fractionated carbon dioxide lasers on photoaged skin.

  Author: Luo YJ, Xu XG, Wu Y, Xu TH, Chen JZ, Gao XH, Chen HD, Li YH.

英文介紹

Journal Of Drugs In Dermatology雜志英文介紹

The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE?/PubMed? that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.

We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality.

Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.